Could a tiny dose of naltrexone help spinal cord injury pain?
NCT ID NCT06723561
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study is testing whether a daily low dose of naltrexone (4.5 mg) can reduce central neuropathic pain and improve quality of life in 10 adults with traumatic spinal cord injury. Participants take the drug for 12 weeks, and researchers measure pain scores and daily function. The goal is to gather initial data to plan a larger, more definitive trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 'Smart Bridge' in the spine help paralyzed patients walk again?
- Spinal zaps may steady blood pressure in spinal cord injury
- Can a simple pill stabilize blood pressure after spinal cord injury?
- Can breathing power boost balance and Well-Being in paralympic athletes?
- Spinal implant + robot rehab: a new hope for walking after injury?
- Can a robotic suit plus spinal stimulation help paralyzed individuals walk again?